Abstract
Background: The endovascular aneurysm repair (EVAR) 2 trial advocated not intervening in those deemed unfit for open abdominal aortic aneurysm repair. In the 14 years since EVAR 2 finished recruiting, there have been advances in endovascular technology and expertise, in addition to improvements in anaesthetic and critical care outcomes. These, in concert with an aging population, have led to greater numbers of elderly patients being treated with EVAR. We sought to determine our outcomes when treating this population.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
